Aytu BioPharma, Inc. (AYTU) Financials
AYTU Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 131.2 million | 98.4 million |
2023-09-30 | 136.5 million | 97.1 million |
2023-06-30 | 136.5 million | 97.1 million |
2023-03-31 | 147.2 million | 106.3 million |
AYTU Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -135000 | 820000 |
2023-09-30 | 9.4 million | 900000 |
2023-06-30 | 9.4 million | 900000 |
2023-03-31 | -2.9 million | 902000 |
AYTU Net Income
No data available :(
AYTU Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 19.5 million | - | - |
2023-09-30 | 23.0 million | - | - |
2023-06-30 | - | - | - |
2023-03-31 | 19.2 million | - | - |
AYTU Shares Outstanding
AYTU Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 524000 | 5.4 million | 6.6 million |
2023-09-30 | - | 465000 | 6.1 million | 8.0 million |
2023-06-30 | - | 465000 | 14.1 million | - |
2023-03-31 | - | 856000 | 7.2 million | 12.8 million |
AYTU Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 22.9 million | 6.7 million |
2023-09-30 | 30.7 million | 12.2 million |
2023-06-30 | 30.7 million | 12.2 million |
2023-03-31 | 22.7 million | 10.0 million |
AYTU
Price: $2.90
52 week price:
Earnings Per Share: -4.01 USD
P/E Ratio: -0.45
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 55600
Ebitda: -9.2 millionMarket Capitalization: 17.9 million